alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 31.1**

 

**CERTIFICATIONS**

 

I, Christopher Weiler, certifythat:

 

1. I have reviewed thisquarterly report on Form 10-Q of On-Site Sourcing, Inc.;

 

2. Based on my knowledge, thisquarterly report does not contain any untrue statement of a material fact oromit to state a material fact necessary to make the statements made, in lightof the circumstances under which such statements were made, not misleading withrespect to the period covered by this quarterly report;

 

3. Based on my knowledge, thefinancial statements, and other financial information included in thisquarterly report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this quarterly report;

 

4. The registrant’s othercertifying officers and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and15d-14) for the registrant and we have:

 

a) designed such disclosurecontrols and procedures to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which thisquarterly report is being prepared;

 

b) evaluated the effectivenessof the registrant’s disclosure controls and procedures as of a date within 90days prior to the filing date of this quarterly report (the “Evaluation Date”);and

 

c) presented in this quarterlyreport our conclusions about the effectiveness of the disclosure controls andprocedures based on our evaluation as of the Evaluation Date;

 

5. The registrant’s othercertifying officers and I have disclosed, based on our most recent evaluation,to the registrant’s auditors and the audit committee of registrant’s board ofdirectors (or persons performing the equivalent function):

 

a) all significant deficienciesin the design or operation of internal controls which could adversely affectthe registrant’s ability to record, process, summarize and report financialdata and have identified for the registrant’s auditors any material weaknessesin internal controls; and

 

b) any fraud, whether or notmaterial, that involves management or other employees who have a significantrole in the registrant’s internal controls; and

 

6. The registrant’s othercertifying officers and I have indicated in this quarterly report whether ornot there were significant changes in internal controls or in other factorsthat could significantly affect internal controls subsequent to the date of ourmost recent evaluation, including any corrective actions with regard tosignificant deficiencies and material weaknesses.

 

 
| /s/ Christopher Weiler  |   |
|-------------------------|--------|
|                    |
| Christopher Weiler      |
| Chief Executive Officer |
| November 14, 2003       |

 

----
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Energy Federal Energy Regulatory Commission [Project No. 4639-033]
 
 
 On September 29, 2021, Ampersand Christine Falls Hydro, LLC filed an application for a subsequent minor license for the 850-kilowatt Christine Falls Hydroelectric Project (Christine Falls Project or project; FERC No. 4639). On November 9, 2023, Commission staff issued a notice of intent to prepare an environmental assessment (EA) to evaluate the effects of relicensing the project. The notice of intent included an anticipated schedule for issuing the EA. By this notice, Commission staff is updating the procedural schedule for completing the EA. The revised schedule is shown below. Further revisions to the schedule may be made as appropriate. Milestone
Target dateIssue EA
October 2024.
 Any questions regarding this notice may be directed to Andy Bernick at (202) 502-8660 or 
                    *andrew.bernick@ferc.gov.* Dated: September 5, 2024. Debbie-Anne A. Reese, Acting Secretary.


[FR Doc. 2024-20593 Filed 9-10-24; 8:45 am] BILLING CODE 6717-01-P
CONSENT
      OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM





We
      consent to the incorporation by reference of our report on the consolidated
      financial statements of ADDvantage Technologies Group, Inc. (“the Company”) as
      of September 30, 2007 and 2006, and for the years then ended, dated December
      21,
      2007, included in this Form 10-K Annual Report of the Company into its
      previously filed Registration Statement on Form S-8 (File Number
      333-110645).








/s/
      HOGAN
& SLOVACEK








Tulsa,
      Oklahoma


December
      21, 2007
[Federal Register Volume 89, Number 174 (Monday, September 9, 2024)]
[Rules and Regulations]
[Pages 72986-72987]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20224]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Office of Foreign Assets Control

31 CFR Part 591


Publication of Venezuela Sanctions Regulations Web General 
License 5P

AGENCY: Office of Foreign Assets Control, Treasury.

ACTION: Publication of web general license.

-----------------------------------------------------------------------

SUMMARY: The Department of the Treasury's Office of Foreign Assets 
Control (OFAC) is publishing one general license (GL) issued pursuant 
to the Venezuela Sanctions Regulations: GL 5P, which was previously 
made available on OFAC's website.

DATES: GL 5P was issued on August 12, 2024. See SUPPLEMENTARY 
INFORMATION for additional relevant dates.

FOR FURTHER INFORMATION CONTACT: OFAC: Assistant Director for 
Licensing, 202-622-2480; Assistant Director for Regulatory Affairs, 
202-622-4855; or Assistant Director for Compliance, 202-622-2490.

SUPPLEMENTARY INFORMATION: 

Electronic Availability

    This document and additional information concerning OFAC are 
available on OFAC's website: https://ofac.treasury.gov.

Background

    On August 12, 2024, OFAC issued GL 5P to authorize certain 
transactions otherwise prohibited by the Venezuela Sanctions 
Regulations (VSR), 31 CFR part 591. GL 5P was made available on OFAC's 
website (https://ofac.treasury.gov) when it was issued. GL 5P 
supersedes GL 5O, which was issued on April 15, 2024. The text of GL 5P 
is provided below.

OFFICE OF FOREIGN ASSETS CONTROL

Venezuela Sanctions Regulations

31 CFR Part 591

GENERAL LICENSE NO. 5P

Authorizing Certain Transactions Related to the Petr[oacute]leos de 
Venezuela, S.A. 2020 8.5 Percent Bond on or After November 12, 2024

    (a) Except as provided in paragraph (b) of this general license, on 
or after

[[Page 72987]]

November 12, 2024, all transactions related to, the provision of 
financing for, and other dealings in the Petr[oacute]leos de Venezuela, 
S.A. 2020 8.5 Percent Bond that would be prohibited by subsection 
l(a)(iii) of Executive Order (E.O.) 13835 of May 21, 2018, as amended 
by E.O. 13857 of January 25, 2019, and incorporated into the Venezuela 
Sanctions Regulations, 31 CFR part 591 (the VSR), are authorized.
    (b) This general license does not authorize any transactions or 
activities otherwise prohibited by the VSR, or any other part of 31 CFR 
chapter V.
    (c) Effective August 12, 2024, General License No. 5O, dated April 
15, 2024, is replaced and superseded in its entirety by this General 
License No. 5P.

Lisa M. Palluconi,

Acting Director Office of Foreign Assets Control.

    Dated: August 12, 2024.

Lisa M. Palluconi,
Acting Director, Office of Foreign Assets Control.
[FR Doc. 2024-20224 Filed 9-6-24; 8:45 am]
BILLING CODE 4810-AL-P
#### Ex parte TAYLOR.

No. 17542.

Court of Criminal Appeals of Texas.

April 3, 1935.

Taylor & Irwin, of Dallas, for appellant.

Lloyd W. Davidson, State’s Atty., of Austin, for the State.

CHRISTIAN, Judge.

By way of habeas corpus, relator sought his release, and he has appealed from an order of the county court of Denton county remanding him to the custody of the sheriff without bail.

On the 10th of March, 1933, relator was adjudged by the county court of Dallas county to be a lunatic and ordered restrained in the State Hospital for the Insane at Wichita Palls. Thereafter he was released on parole. On the 26th of June, 1934, while on parole, a complaint was filed against relator in Denton county charging him with unlawfully carrying a pistol; it being alleged that the offense occurred on the 13th of October, 1932. He was arrested on said misdemeanor charge and released on bail. On the 30th of July, 1934, said cause was called for trial, and relator appeared and answered that he had theretofore been adjudged insane. Atrial was had on the issue of insanity, resulting in the court entering a judgment finding relator to be insane and ordering the sheriff to deliver him to the proper state hospital. The judgment provided that relator should be returned to the county court of Denton county to be dealt with according to law when he had been restored to sanity. Relator was again confined in the State Hospital for the Insane at Wichita Palls. On the 20th of January, 1935, he was discharged, and the county court of Dallas county entered an order setting aside the judgment of lunacy theretofore entered by said court. Relator was delivered to the sheriff of Denton county and placed in jail to await trial in the case charging him with carrying a pistol. ■He has been denied bail.

Under the circumstances reflected by the record, the opinion is expressed that relator is entitled to be released upon entering into proper bond conditioned as required by law. Therefore the judgment remanding him is reversed and bail granted in the sum of $300.

• PER CURIAM.

The foregoing opinion of the Commission of Appeals has been examined by the judges of the Court of Criminal Appeals and approved by the court.
<PAGE>   1
EXHIBIT 11.1

                          CARDIAC PATHWAYS CORPORATION

             STATEMENT REGARDING COMPUTATION OF NET LOSS PER SHARE


<TABLE>
<CAPTION>
                                                 Three months ended           Six months ended
                                                    December 31,                 December 31,
                                             --------------------------    --------------------------
                                                1996            1995           1996           1995
                                             -----------    -----------    -----------    -----------
<S>                                          <C>            <C>            <C>            <C>         
Net loss                                     $(2,868,860)   $(2,363,353)   $(5,419,147)   $(4,418,474)
                                             ===========    ===========    ===========    ===========

Weighted average common shares outstanding     9,318,000        870,000      9,301,000        870,000

Common equivalent shares:
  Convertible preferred stock outstanding                     5,450,000                     5,450,000

Shares related to SAB No. 55, 64, and 83                        655,000                       655,000
                                             -----------    -----------    -----------    -----------

Total weighted average shares and common
  equivalent shares outstanding                9,318,000      6,975,000      9,301,000      6,975,000
                                             ===========    ===========    ===========    ===========

Net loss per share                           $     (0.31)                  $     (0.58)
                                             ===========                   ===========

Pro forma net loss per share                                $     (0.34)                  $     (0.63)
                                                            ===========                   ===========
</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                  1,000                 
       
<S>                                <C>
<PERIOD-TYPE>                      YEAR
<FISCAL-YEAR-END>                  DEC-31-1998
<PERIOD-START>                     JAN-01-1998
<PERIOD-END>                       DEC-31-1998
<CASH>                                  24,222
<SECURITIES>                            45,830
<RECEIVABLES>                           21,550
<ALLOWANCES>                             1,679
<INVENTORY>                                  0
<CURRENT-ASSETS>                        92,144
<PP&E>                                  22,957
<DEPRECIATION>                           9,591
<TOTAL-ASSETS>                         109,121
<CURRENT-LIABILITIES>                   15,725
<BONDS>                                      0
<PREFERRED-MANDATORY>                        0
<PREFERRED>                                  0
<COMMON>                                   127
<OTHER-SE>                              93,269
<TOTAL-LIABILITY-AND-EQUITY>           109,121
<SALES>                                103,987
<TOTAL-REVENUES>                       103,987
<CGS>                                   56,035
<TOTAL-COSTS>                           79,393
<OTHER-EXPENSES>                             0
<LOSS-PROVISION>                             0
<INTEREST-EXPENSE>                           0
<INCOME-PRETAX>                         27,254
<INCOME-TAX>                            10,217
<INCOME-CONTINUING>                     17,037
<DISCONTINUED>                               0
<EXTRAORDINARY>                              0
<CHANGES>                                    0
<NET-INCOME>                            17,037
<EPS-PRIMARY>                             1.34
<EPS-DILUTED>                             1.30

        

</TABLE>
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[S. 2280 Introduced in Senate (IS)]

<DOC>

115th CONGRESS
  2d Session
                                S. 2280

   To amend title 38, United States Code, to ensure the Secretary of 
Veterans Affairs permits the display of Battlefield Crosses in national 
                  cemeteries, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 4, 2018

Mr. Portman (for himself and Mr. Brown) introduced the following bill; 
which was read twice and referred to the Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
   To amend title 38, United States Code, to ensure the Secretary of 
Veterans Affairs permits the display of Battlefield Crosses in national 
                  cemeteries, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Fallen Warrior Battlefield Cross 
Memorial Act''.

SEC. 2. DISPLAY OF BATTLEFIELD CROSSES IN NATIONAL CEMETERIES.

    Section 2403 of title 38, United States Code, is amended by adding 
at the end the following new subsection:
    ``(d)(1) The Secretary may not prohibit the display of a 
Battlefield Cross in any national cemetery.
    ``(2) In this subsection, the term `Battlefield Cross' means a 
memorial monument in honor of fallen members of the Armed Forces that 
may include a replica of an inverted rifle, boots, helmets, and 
identification tag.''.
                                 <all>
```
United States Court of Appeals

for the Fifth Circuit

No. 19-11321

Summary Calendar

United States of America, 

Plaintiff—Appellee,

versus

Severo Elizalde-Abelardo, 

Defendant—Appellant.

Appeal from the United States District Court

for the Northern District of Texas

USDC No. 3:17-CR-341-1

Before Wiener, Dennis, and Haynes, Circuit Judges.

Per Curiam:*

The attorney appointed to represent Severo Elizalde-Abelardo has 

moved for leave to withdraw and has filed a brief in accordance with Anders 

v. California, 386 U.S. 738 (1967), and United States v. Flores, 632 F.3d 229 

(5th Cir. 2011). Elizalde-Abelardo has not filed a response. We have 

* Pursuant to 5th Circuit Rule 47.5, the court has determined that this 

opinion should not be published and is not precedent except under the limited 

circumstances set forth in 5th Circuit Rule 47.5.4.

United States Court of Appeals

Fifth Circuit

FILED

September 28, 2021

Lyle W. Cayce

Clerk

Case: 19-11321 Document: 00516033982 Page: 1 Date Filed: 09/28/2021
No. 19-11321

2

reviewed counsel’s brief and the relevant portions of the record reflected 

therein. We concur with counsel’s assessment that the appeal presents no 

nonfrivolous issue for appellate review. Accordingly, counsel’s motion for 

leave to withdraw is GRANTED, counsel is excused from further 

responsibilities herein, and the APPEAL IS DISMISSED. See 5th Cir. 

R. 42.2.

Case: 19-11321 Document: 00516033982 Page: 2 Date Filed: 09/28/2021
[Federal Register Volume 89, Number 175 (Tuesday, September 10, 2024)]
[Notices]
[Page 73422]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20369]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel; Review of Limited Competition CTSA 
R03 Applications.
    Date: October 21, 2024.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Center for Advancing Translational Sciences, 
National Institutes of Health, 9609 Medical Center Drive, Rockville, 
MD 20892.
    Contact Person: Victor Henriquez, Ph.D., Scientific Review 
Officer, Office of Scientific Review, National Center for Advancing 
Translational Sciences, National Institutes of Health, 9609 Medical 
Center Drive, Suite 1E504, Bethesda, MD 20892, (301) 435-0813, 
<a href="/cdn-cgi/l/email-protection#0f676a617d667e7a794f626e66632161666721686079"><span class="__cf_email__" data-cfemail="e68e8388948f979390a68b878f8ac8888f8ec8818990">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B--Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS)

    Dated: September 4, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2024-20369 Filed 9-9-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 3.13

CERTIFICATE OF FORMATION

OF

U.S.
PROPANE, L.L.C.

This Certificate of Formation of U.S. Propane, L.L.C. (the Company) is
being executed by the undersigned for the purpose of forming a limited liability company pursuant to the Delaware Limited Liability Company Act.



| | 1. | The name of the Company is U.S. Propane, L.L.C.
| | -- | -----------------------------------------------



| | 2. | The name and address of the registered agent of the Company shall be The Corporation Trust Company, 1209 Orange Street, Wilmington, Delaware 19801.
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------



| | 3. | The address of the registered office of the Company in Delaware is 1209 Orange Street, Wilmington, Delaware 19801.
| | -- | ------------------------------------------------------------------------------------------------------------------

IN WITNESS WHEREOF, the undersigned, an authorized person or agent or attorney-in-fact of the Company, has caused
this Certificate of Formation to be duly executed as of the 2nd day of March, 2000.



/s/ Royston K. EustaceRoyston K. EustaceAuthorized Person
Court of Appeals

Sixth Appellate District of Texas

JUDGMENT

Ilester Carter, Appellant

No. 06-12-00125-CR v.

The State of Texas, Appellee

Appeal from the 124th District Court of 

Gregg County, Texas (Tr. Ct. No. 39661-

B). Opinion delivered by Chief Justice 

Morriss, Justice Carter and Justice Moseley

participating.

As stated in the Court’s opinion of this date, we find no error in the judgment of the court 

below. We affirm the judgment of the trial court.

We note that the appellant, Ilester Carter, has adequately indicated his inability to pay 

costs of appeal. Therefore, we waive payment of costs.

RENDERED DECEMBER 20, 2012

BY ORDER OF THE COURT

JOSH R. MORRISS, III

CHIEF JUSTICE

ATTEST:

Debra K. Autrey, Clerk